| 8.14 Data as of May 17 |  +0.06 / +0.74%Today’s Change | 6.92 Today|||52-Week Range 17.48 | -27.23% Year-to-Date |
| Biotech Stock Mailbag: Vical, Sangamo, Spectrum Pharma May 17 / TheStreet.com | Spectrum Pharma Reports 1Q Loss - Analyst Blog May 14 / Zacks.com |
| The 5 Dumbest Things on Wall Street This Week: May 17 May 17 / TheStreet.com | SEC Is Investigating Spectrum Pharma May 13 / TheStreet.com |
| Previous close | 8.08 |
| Today’s open | 8.09 |
| Day’s range | 8.03 - 8.18 |
| Volume | 711,269 |
| Average volume (3 months) | 1,469,884 |
| Market cap | $488.6M |
| Dividend yield | -- |
| Earnings growth (last year) | +73.81% |
| Earnings growth (this year) | -114.50% |
| Earnings growth (next 5 years) | +22.00% |
| Revenue growth (last year) | +38.73% |
| P/E ratio | 11.5 |
| Price/Sales | 2.45 |
| Price/Book | 1.72 |
| Today’s change | Today’s % change | |
|---|---|---|
| AVNRAvanir Pharmaceutica... | +0.02 | +0.61% |
| SCRSimcere Pharmaceutic... | -0.01 | -0.11% |
| CMRXChimerix Inc | -0.29 | -1.44% |
| ECYTEndocyte Inc | +0.12 | +0.84% |
| Next reporting date | August 13, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $267.7M |
| Annual profit (last year) | $94.5M |
| Net profit margin | 35.32% |
Sector Health Technology |
Industry Biotechnology |
Chairman, President & Chief Executive Officer Rajesh C. Shrotriya, MD |
Chief Operating Officer & Executive Vice President Kenneth Joseph Keller, MBA |
Corporate headquarters Henderson, Nevada |
.
